Modus Medical Devices Inc.

Published purpose

ITEA - 20052 SIGNET led by Philips (Netherlands). As part of the international consortium project “SIGNET”, this project will focus on developing efficient image-guided treatment workflows to replace currently complex procedures in cardiology, oncology and neurology. We develop systems and technologies, AI-enabled products and solutions, necessary to ultimately realize the North Star of single-episode, personalized, dose-adaptive, high-precision Magnetic Resonance guided treatments and interventions. These technologies and solutions aim to improve patient comfort, safety, treatment outcome, staff availability and economic viability. We focus on use cases where alternative image guidance approaches are either not feasible or where the value of direct MR visualization is obvious.